Aprea Therapeutics, Inc.: cash_and_restricted_cash
| Value | {"amount": 69803846, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2021-06-30) |
| Status | current |
| Entity | Aprea Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:02:22.995812+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d2ac93a3-ac4c-4145-9f81-492d9be9c0a9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-22-013512Retrieved: 2026-08-19T18:02:22.995812+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001781983/cash-and-restricted-cash/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d2ac93a3-ac4c-4145-9f81-492d9be9c0a9
History
- supersedes {"amount": 69803845, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} (evidence 0001558370-21-011504)